Multiple Sclerosis, Primary Progressive: Clinical Trials

1 trial for Multiple Sclerosis, Primary Progressive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow Multiple Sclerosis, Primary Progressive: new trials by email Literature Review of Multiple Sclerosis, Primary Progressive trials Research Report on Multiple Sclerosis, Primary Progressive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis
Orca-Q, myeloablative regimen - Primary Progressive Multiple Sclerosis, Multiple Sclerosis
Phase 1Not yet recruitingStanford University102025-03-012025-03-28

Narrower conditions

Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Chronic Disease (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Busulfan (1)  ·  Thiotepa (1)  ·  fludarabine (1)

Sponsors

Stanford University (1)